TipRanks
Go Ultimate55% OFF

Viking Therapeutics (0VQA) Balance Sheet

Viking Therapeutics Balance Sheet

Viking Therapeutics's total assets for Q3 2026 were $977.17M, an increase of 87.23% from the previous quarter. GB:0VQA total liabilities were $388.57M for the fiscal quarter, a 242.11% an increase from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
$ 715.73M$ 908.32M$ 368.49M$ 168.53M$ 210.66M
$ 76.67M$ 28.04M$ 20.07M$ 23.21M$ 8.78M
$ 639.06M$ 880.28M$ 348.42M$ 145.32M$ 201.88M

Currency in USD

Viking Therapeutics Debt to Assets

0400M800M1.2B0 %15 %30 %45 %LiabilitiesDebt to Assets201720182019202020212022202320242025AssetsLiabilitiesDebt to Assets